About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Phase I Study of ICP-332 in Healthy Subjects

NCT06530966·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

InnoCare Pharma Inc.

Age

18–55

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

1. Voluntarily sign the informed consent form
2. Body mass index (BMI) of ≥ 18.5 kg/m2 and \< 30 kg/m2
3. Male or infertile female subjects who are between 18-55 years old (inclusive)

You may not be if

1. Significant current or past acute or chronic disease or condition.
2. A history of tuberculosis or current active/latent infection.
3. With a history of drug or food allergy, or allergy to any of the composition components of the study drug, or allergic disease.
4. Subjects with clinically significant abnormalities in the screening examinations.

The record

StatusCompleted

PhasePhase 1

Taking part24

StartedJul 2024

UpdatedApr 14, 2026

Conditions

Healthy Subjects

Where1

Pharmaron CPC Inc.
Baltimore, Maryland, United States

Clareo Health | Phase I Study of ICP-332 in Healthy Subjects